Brainsway Ltd

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. Show More...

  • Website https://www.brainsway.com
  • Sector Healthcare
  • Industry Medical Devices
  • Last Quote 10.20 USD
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -1.1 -1.12 -0.56 -0.34 -0.96 -0.78 -1.0 -1.0
    Dividends USD
    Payout Ratio % *
    Shares Mil 6.0 7.0 7.0 7.0 7.0 8.0 10.0 10.0
    Book Value Per Share * USD 2.36 2.18
    Free Cash Flow Per Share * USD -1.13
    Return on Assets % -25.4 -17.02 -11.36 -30.02 -25.59 -33.14 -33.14
    Financial Leverage (Average) 1.65 1.72 1.94 2.12 3.4 1.6 1.6
    Return on Equity % -42.02 -28.71 -20.68 -61.32 -65.87 -66.26 -66.26
    Return on Invested Capital % -42.61 -28.84 -20.78 -49.22 -48.03 -59.02 -59.02
    Interest Coverage -78.14 -16.71 -23.89 -23.89
    Current Ratio 3.62 3.04 2.98 2.92 1.62 4.29 4.29
    Quick Ratio 3.61 3.01 2.84 2.85 1.55 4.15 4.15
    Debt/Equity 0.21 0.3